Netflix’s growth story takes a high-risk turn
Netflix just crossed 325 million subscribers and beat revenue with $12.1 billion in Q4, yet its stock slid as markets focused elsewhere.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Netflix just crossed 325 million subscribers and beat revenue with $12.1 billion in Q4, yet its stock slid as markets focused elsewhere.
Lexicon Pharmaceuticals (NASDAQ:LXRX) successfully completed an End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration for its lead pain candidate, pilavapadin.
City Holding Company (NASDAQ:CHCO) capped a historic 2025 with record annual net income of $130.5 million, as the West Virginia-based lender defied industry-wide margin pressures through robust loan growth and stellar efficiency.
Dr. Reddy’s Laboratories (NYSE:RDY) reported fiscal third-quarter revenue that surpassed analyst expectations Wednesday, as explosive growth in emerging markets and a resilient domestic business in India helped offset a steep decline in its North American generic portfolio.
Truist Financial (NYSE:TFC) reported fourth-quarter adjusted earnings that cleared Wall Street hurdles, supported by a significant $10 billion share repurchase authorization and expanding margins.
Greene County Bancorp (NASDAQ:GCBC) reported a surge in profitability, achieving the highest quarterly and six-month earnings in its 137-year history.
Smithfield Foods (NASDAQ:SFD) announced Wednesday that it will acquire iconic hot dog maker Nathan’s Famous (NASDAQ:NATH) in an all-cash transaction valued at $102 per share, or approximately $450 million in enterprise value.
Beneficient (NASDAQ:BENF) shares are in focus Wednesday after a federal court granted final approval to a binding settlement resolving all claims related to the collapse of GWG Holdings against the company and its leadership.
Revelation Biosciences (NASDAQ:REVB) announced it has reached a milestone agreement with the FDA on an "expedient" approval pathway for Gemini, its lead candidate for the treatment of Acute Kidney Injury (AKI).
Lisata Therapeutics (NASDAQ:LSTA) shares soared Wednesday morning after the clinical-stage biotech announced a binding agreement to be acquired by privately held Kuva Labs.
Ionis Pharmaceuticals (NASDAQ:IONS) and Otsuka Pharmaceutical achieved a major regulatory victory Wednesday as the European Commission (EC) granted marketing authorization for DAWNZERA (donidalorsen).
Community Trust Bancorp (NASDAQ:CTBI) delivered a record-shattering 2025, capped by a fourth quarter that saw net income surge to $27.3 million—a 21% increase over the same period last year.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade